ESR1 and breast cancer: In addition, expression of estrogen receptors is a known feature of luminal A and B subtypes of breast cancer[38], and all of the ER positive xenografts were found to be luminal A or B. Overall, the association between histopathological characteristics and intrinsic molecular subclassification was in accordance with previously published data[39].